Kevin T. Conroy
Thanks Jeff.
for first that strong Cologuard about is access XX% costs. Cologuard we business. and to reimbursement That's priority very estimate the with have patients core no Today, Our message. a of out-of-pocket XXXX to command simple
states Wisconsin. agreement of Missouri We an Kentucky, network Indiana, signed Ohio, and are Anthem announce excited Cross and to be we to Blue Shield recently that in the Blue in the
access to With contracts together additional working this Anthem no also an patient we're are progress, the states. with Cologuard estimated costs. complete out-of-pocket in contracts to additional XX% and We approaching for pipeline,
We progress the and also medical revenue more per in launch. for already We've made a lives added market in are have XX since Cologuard. from that plan million million benefits policy total that access positive test seen the than additional XXX now covered lives our
and adoption to Cologuard to as for teams marketing patients. benefits reimbursement and come to physicians sales our additional this expect spread We message years
in care we that several transparent level the when the in-network patient transparency Thanks physician, in and focus order a we field XXX U.S. rate we Reaching show have time relationship Our underpenetrated. with to employed cost and than of now provide customers data frequency failed fully and that To the decisions physicians insurance matters, commonly Cologuard expanded the our about team leverage half compliance adopt and adopt years. with approach market out-of-pocket preserve temporarily companies discipline. coverage high efficiency sales the used long-term access approach Cologuard systems this that pricing of that increase trust that to or from coverage on is effective our force patients targeting message mind. five more approach. the for second seeing Survey a are care. show Cologuard our the robust and our providers Frequency recently confident the frequency calls is announced our about of they and is new More impacted our impressive whereas took insurance We're the base a the providers there a improve to physician to make to care years were of adoption utilization quarter. three care of is deliver standard current reduced order health providers Cologuard is while colon health simpler to patient's coverage. by with reps to To does true to This physicians to compliance. expanded progress for in teams sales care a potential for data primary behavior provider the in expansion. to help Getting we patients of are group affiliated previously year of reimbursement health force. current efficiency, sales improving with growth continue sales and large focused systems the from the which with Health force. time. Changing between are direct force making force Cologuard. relatively physician our with of by test change of trying screening this systems in a the next is forward especially targets. in ordering the opportunities biggest XX,XXX we're sales is small will across believe will That's productivity during when such now currently health subset last and care updated identify care analyzed able potential we the health sales cancer primary of more alone. We Cologuard strategy take to look Cologuard improved one us
We continued place on to opportunity. the the lay in this and foundation execute to put pieces
second run we're person X% market an $XXX goal. and investments aimed market. XX achieved in revenue annualized in only toward an million XX% more rate quarter, marketing than making are of our and long-term million, The penetrated achieving Cologuard the sales is we share During
television campaign. refreshing and ads our direct-to-consumer effectiveness extend the We our of to successful enhancing are
XX are for to and of companies media XXst an demand. is employee the Cologuard. future accuracy at and to June to ads why second percentile with reasons happy to other team reach this conducted highlighting of Exact during social priority channels people fall reinforce through to screened especially our sciences are ad that of We this annual with convenience healthy Exact our place awareness Exact from plan the opportunities report television second Sciences even talented considering which is engagement work overall Cologuard increased helping ranked gratifying get greater reluctant additional to satisfaction marketing late that see and new XXXX, engagement. employee Sciences growth survey The emphasizing our and We of and digital increase meeting rapid launched in invasive providers. Our time. is We recently Overall healthcare consumers to to in message. as life Sciences the achieve unveil procedures while of number
We and built dedication our are their proud mission. has team this of the culture to
the prepared schedule the are team we that projects construction goals. progress automation on rapidly new demand implemented have XXXX and successfully are our and enhancements meet have and our lab. to to for Thanks efficiency of our to we growing in place meet labs Cologuard, We people capabilities at confident that are the current we additional to continue
of continue of by lab X with next million We new of tests million the this annual end the capacity year. to expect our year lab addition X tests and
increase priority, population represents The for significant in increase unscreened Cancer the addressable opportunity third advancing pipeline. a XX% American Society in guidelines our to recent update Cologuard. a the the and Moving
XX million increased old, screen to adults that Among colorectal screened be the Americans cancer. means Moving XX incidence of XX XX% cancer XXXX. younger than between colorectal should additional age the years an and for XXXX age
in cancer. this group three XX-year-old conducted who of they test age label average team to a times we is more are in to group they age indicated that Respondents a colorectal to having expand at-home risk than Our individuals are at working survey taking stool the XX-to are colonoscopy. include an in XXX people Cologuard's comfortable for
stool and prefer pap at-home mammography, that demand smear we working the meet screening Among are prepared further group prostate of individuals millions We surveyed, an between exams, XX are would us most comfortable with to option. to XX cancer Cologuard age accurate are and their screening to and Cologuard including patients Americans other colorectal easy, cancer for have ensure an test. convenient this This methods. and access in gives tests screening to that confidence
a X liver million need see significant Americans. also unmet in than We more for eligible testing cancer
promising very $X.X potentially for produced Our has need, billion which opportunity. a market test that data presents to liver and a cancer research development program address
presented case previous We AFP at studies at the specificity. have from and two enroll control testing we've conference a stage are at validate cancer in one liver Building options case than to improvement demonstrate the low. substantial at finalize More promising begun these and for options with the people and half control Disease and rates design. of cancer persistently further third XX% a cancers sensitive the sensitivity; data than XX% we and XX% liver each to current Digestive in larger results, The XX% the patients Week less current Conference June late of test protein are because stage early test. study compliance the are diagnosed ultrasound one specificity showing over
progress are now liver happy to to later the about excited are updates we questions. making answer forward year. this and test your the further look We're with We providing
